Atlas Trials

Jinghui Wang

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jinghui Wang

RecordFirmDate
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. (NCT06421298)Jinghui Wang2024-05-17

Track Jinghui Wang automatically

Every clearance here is in the API, with alerts when new ones post.